The measurement of fatigability severity in individuals with multiple sclerosis and healthy controls
Copyright © 2024 Elsevier B.V. All rights reserved..
BACKGROUND: Multiple Sclerosis (MS) is a chronic disease that substantially diminishes one's ability to undertake daily living activities. Fatigue has been reported by at least 80 % of persons with MS (PwMS). Yet, little is known concerning the quantification of fatigability using prolonged walking tests.
OBJECTIVES: To compare fatigability severity measures using the 10-minute walk test for PwMS against age- and gender-matched healthy controls (HCs).
METHODS: Participants included 53 ambulatory PwMS and 49 HCs. Perceived fatigability was measured by dividing a participant's change in self-reported tiredness by the number of meters walked. Performance fatigability was calculated by dividing the change in walking speed (at 2.5 and 10 min) by the total distance walked in meters.
RESULTS: There was a significant difference in perceived fatigability between PwMS and HCs (mean difference: 2.73 ± 0.83; p = 0.001) and in performance fatigability (mean difference: 0.24 ± 0.11; p = 0.01). Moreover, there were significant differences in speed and distance at all time points (p ≤ 0.05) between PwMS and HCs.
CONCLUSIONS: PwMS have significant walking deficits as reflected by greater fatigability in both perceived and performance measures. These methods can enhance therapeutic strategies that improve the walking performances of PwMS.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:85 |
|---|---|
| Enthalten in: |
Multiple sclerosis and related disorders - 85(2024) vom: 20. März, Seite 105568 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Alharbi, Mutasim D [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Fatigability |
|---|
| Anmerkungen: |
Date Revised 23.03.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.msard.2024.105568 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370105133 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370105133 | ||
| 003 | DE-627 | ||
| 005 | 20240324235433.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240324s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.msard.2024.105568 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1345.xml |
| 035 | |a (DE-627)NLM370105133 | ||
| 035 | |a (NLM)38520949 | ||
| 035 | |a (PII)S2211-0348(24)00147-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Alharbi, Mutasim D |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The measurement of fatigability severity in individuals with multiple sclerosis and healthy controls |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024 Elsevier B.V. All rights reserved. | ||
| 520 | |a BACKGROUND: Multiple Sclerosis (MS) is a chronic disease that substantially diminishes one's ability to undertake daily living activities. Fatigue has been reported by at least 80 % of persons with MS (PwMS). Yet, little is known concerning the quantification of fatigability using prolonged walking tests | ||
| 520 | |a OBJECTIVES: To compare fatigability severity measures using the 10-minute walk test for PwMS against age- and gender-matched healthy controls (HCs) | ||
| 520 | |a METHODS: Participants included 53 ambulatory PwMS and 49 HCs. Perceived fatigability was measured by dividing a participant's change in self-reported tiredness by the number of meters walked. Performance fatigability was calculated by dividing the change in walking speed (at 2.5 and 10 min) by the total distance walked in meters | ||
| 520 | |a RESULTS: There was a significant difference in perceived fatigability between PwMS and HCs (mean difference: 2.73 ± 0.83; p = 0.001) and in performance fatigability (mean difference: 0.24 ± 0.11; p = 0.01). Moreover, there were significant differences in speed and distance at all time points (p ≤ 0.05) between PwMS and HCs | ||
| 520 | |a CONCLUSIONS: PwMS have significant walking deficits as reflected by greater fatigability in both perceived and performance measures. These methods can enhance therapeutic strategies that improve the walking performances of PwMS | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Fatigability | |
| 650 | 4 | |a Fatigue | |
| 650 | 4 | |a Multiple sclerosis | |
| 650 | 4 | |a Perceived fatigability severity | |
| 650 | 4 | |a Performance fatigability severity | |
| 650 | 4 | |a Ten-minute walk test | |
| 700 | 1 | |a Khan, Fayaz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Multiple sclerosis and related disorders |d 2012 |g 85(2024) vom: 20. März, Seite 105568 |w (DE-627)NLM219118388 |x 2211-0356 |7 nnns |
| 773 | 1 | 8 | |g volume:85 |g year:2024 |g day:20 |g month:03 |g pages:105568 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.msard.2024.105568 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 85 |j 2024 |b 20 |c 03 |h 105568 | ||